Challenges for Alzheimer's Disease Therapy: Insights from Novel Mechanisms Beyond Memory Defects

Frontiers in Neuroscience
Rudimar L FrozzaFernanda G De Felice

Abstract

Alzheimer's disease (AD), the most common form of dementia in late life, will become even more prevalent by midcentury, constituting a major global health concern with huge implications for individuals and society. Despite scientific breakthroughs during the past decades that have expanded our knowledge on the cellular and molecular bases of AD, therapies that effectively halt disease progression are still lacking, and focused efforts are needed to address this public health challenge. Because AD is classically recognized as a disease of memory, studies have mainly focused on investigating memory-associated brain defects. However, compelling evidence has indicated that additional brain regions, not classically linked to memory, are also affected in the course of disease. In this review, we outline the current understanding of key pathophysiological mechanisms in AD and their clinical manifestation. We also highlight how considering the complex nature of AD pathogenesis, and exploring repurposed drug approaches can pave the road toward the development of novel therapeutics for AD.

References

Mar 1, 1992·Journal of Clinical and Experimental Neuropsychology·S CraftL D Baker
Jul 1, 1992·Journal of Neuropathology and Experimental Neurology·E MasliahR D Terry
Feb 1, 1989·Journal of Neurology, Neurosurgery, and Psychiatry·W R GibbA J Lees
Mar 1, 1996·Journal of the American Geriatrics Society·H WhiteG Fillenbaum
Nov 1, 1996·Diabetologia·A OttM M Breteler
Nov 26, 1998·The Journal of Biological Chemistry·W Q QiuD J Selkoe
Dec 22, 1999·Neurology·A OttM M Breteler
May 26, 2001·Science·N IwataT C Saido
Aug 17, 2002·Biological Psychiatry·Constantine G Lyketsos, Jason Olin
Oct 26, 2002·Science·Dennis J Selkoe
Dec 19, 2002·Journal of Biomedicine & Biotechnology·George PerryMark A. Smith
Dec 25, 2002·The Journal of Biological Chemistry·W Blaine StineMary Jo LaDu
Mar 14, 2003·Proceedings of the National Academy of Sciences of the United States of America·Wesley FarrisSuzanne Guenette
May 21, 2003·Archives of Neurology·Robert C GreenLindsay Farrer
Jan 30, 2004·Diabetes·Juliette JansonPeter C Butler
Feb 8, 2005·Proceedings of the National Academy of Sciences of the United States of America·Dimitra G GeorganopoulouChad A Mirkin
Feb 17, 2005·Journal of the American Chemical Society·Amanda J HaesRichard P Van Duyne
Jul 19, 2005·Nature Neuroscience·Eric M SnyderPaul Greengard
Dec 2, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·F RoselliO F X Almeida
Apr 22, 2006·Journal of Alzheimer's Disease : JAD·Nataniel Lester-CollSuzanne M de la Monte
May 3, 2006·Archives of General Psychiatry·Raymond L OwnbyDavid Loewenstein
Jun 21, 2006·Expert Review of Neurotherapeutics·Sergio E Starkstein, Romina Mizrahi
Aug 1, 2006·Lancet·Kaj BlennowHenrik Zetterberg
Dec 8, 2006·The American Journal of Psychiatry·John G CsernanskyJohn C Morris
Dec 15, 2006·Nature·Gökhan S Hotamisligil
Jan 16, 2007·Journal of Neuroimmunology·Michael T Heneka, M Kerry O'Banion
Feb 9, 2007·Journal of Neurochemistry·Dominic M Walsh, Dennis J Selkoe
Mar 1, 2007·Protein Science : a Publication of the Protein Society·Sungmun LeeTheresa A Good
Mar 16, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ganesh M ShankarBernardo L Sabatini
Apr 4, 2007·Neurobiology of Aging·Fernanda G De FeliceWilliam L Klein
Apr 13, 2007·Neuro-degenerative Diseases·Verena H Finder, Rudi Glockshuber

❮ Previous
Next ❯

Citations

Oct 26, 2018·The British Journal of Radiology·Giuseppe BarisanoMeng Law
Jul 6, 2019·Frontiers in Neurology·Wenbin WanYangtai Guan
Jan 1, 2020·Biomolecules·Gabriela Dumitrita StanciuDaniela Carmen Ababei
Jan 11, 2020·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Andrea L Gilmore-BykovskyiMegan Zuelsdorff
Dec 10, 2019·Current Pharmaceutical Design·Giuseppe CarusoSara Merlo
Jun 30, 2018·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Maurizio SeverinoBente Finsen
Sep 19, 2019·Pharmaceutical Research·Bruna Dos Santos RodriguesJagdish Singh
Feb 1, 2020·Current Neuropharmacology·Sara MerloMaria Angela Sortino
Jun 9, 2018·International Journal of Molecular Sciences·Yongfeng ZhangDi Wang
May 16, 2019·Neural Regeneration Research·Edwin E Reza-ZaldivarAlejandro A Canales-Aguirre
Feb 23, 2020·Frontiers in Endocrinology·Ygor Parladore SilvaRudimar Luiz Frozza
Jan 3, 2020·Neuromolecular Medicine·Jinsu ParkDong-Gyu Jo
Jan 24, 2020·Frontiers in Aging Neuroscience·Miren EttchetoAntonio Camins
Mar 21, 2020·Frontiers in Neuroscience·Kathrin M KniewallnerLudwig Aigner
Oct 4, 2020·Marine Drugs·Raquel MateosHerminia Domínguez
Oct 3, 2020·Journal of Affective Disorders·Nanci Moreira SaldanhaPaula Villela Nunes
Nov 20, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Maria A TikhonovaElena K Khlestkina
Jan 17, 2021·European Journal of Pharmacology·Shilpa Kumari, Rahul Deshmukh
Mar 12, 2021·Critical Reviews in Food Science and Nutrition·Abdur RaufKannan R R Rengasamy
May 29, 2021·Frontiers in Synaptic Neuroscience·Marta Díaz GonzálezShira Knafo
Apr 22, 2020·Molecular Pharmaceutics·Bruna Dos Santos RodriguesJagdish Singh
Aug 28, 2021·Healthcare·Ana G Sánchez-Reyna On Behalf Of The Alzheimer's Disease Neuroimaging Initiative

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
pharmacotherapy

Clinical Trials Mentioned

NCT01767909
NCT01255163
NCT01843075

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Karl HerrupSamantha Budd
Journal of Alzheimer's Disease : JAD
Teng JiangLan Tan
Journal of Hematology & Oncology
Xue Yang, Jianxiang Wang
Journal of the American Society of Nephrology : JASN
Michael Zeisberg, Eric G Neilson
© 2022 Meta ULC. All rights reserved